{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:42:16Z","timestamp":1791182536007,"version":"4.1.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1097\/md.0b013e3181779b53","type":"journal-article","created":{"date-parts":[[2008,5,26]],"date-time":"2008-05-26T03:05:17Z","timestamp":1211771117000},"page":"152-159","source":"Crossref","is-referenced-by-count":54,"title":["Legionella Pneumonia in Cancer Patients"],"prefix":"10.1097","volume":"87","author":[{"given":"Kalen L.","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa H.","family":"Miceli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Tarrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Kontoyiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-3-20210226","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/jac\/dki186","article-title":"Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes.","volume":"56","author":"Baltch","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"R4-3-20210226","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1086\/342903","article-title":"Trends in legionnaires disease, 1980-1998: declining mortality and new patterns of diagnosis.","volume":"35","author":"Benin","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R5-3-20210226","first-page":"61","article-title":"Nosocomial legionnaires' disease in a bone marrow transplant unit.","volume":"7","author":"Benz-Lemoine","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"R6-3-20210226","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1600-0609.1981.tb01383.x","article-title":"Legionnaires' disease in leukaemic reticuloendotheliosis.","volume":"25","author":"Berlin","year":"1980","journal-title":"Scand J Haematol"},{"key":"R7-3-20210226","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/428049","article-title":"Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides.","volume":"40","author":"Blazquez Garrido","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R8-3-20210226","first-page":"193","article-title":"Infectious complications in leukemic patients.","volume":"19","author":"Bodey","year":"1982","journal-title":"Semin Hematol"},{"issue":"RR-1","key":"R9-3-20210226","first-page":"1","article-title":"Guidelines for prevention of nosocomial pneumonia.","volume":"46","year":"1997","journal-title":"MMWR Recomm Rep"},{"key":"R11-3-20210226","first-page":"132","article-title":"Legionella: a major opportunistic pathogen in transplant recipients.","volume":"13","author":"Chow","year":"1998","journal-title":"Semin Respir Infect"},{"key":"R12-3-20210226","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/archinte.1984.00350220095021","article-title":"Legionnaires' disease and hairy-cell leukemia. An unfortuitous association?","volume":"144","author":"Cordonnier","year":"1984","journal-title":"Arch Intern Med"},{"key":"R13-3-20210226","first-page":"116","article-title":"Clinical features of legionnaires' disease.","volume":"13","author":"Cunha","year":"1998","journal-title":"Semin Respir Infect"},{"issue":"Suppl 3","key":"R14-3-20210226","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1093\/clind\/21.Supplement_3.S265","article-title":"Antimicrobial chemotherapy for legionnaires' disease: a review.","volume":"21","author":"Edelstein","year":"1995","journal-title":"Clin Infect Dis"},{"key":"R15-3-20210226","first-page":"474","article-title":"Legionella sp pneumonia in patients with hematologic diseases. A study of 10 episodes from a series of 67 cases of pneumonia.","volume":"84","author":"Fernandez-Aviles","year":"1999","journal-title":"Haematologica"},{"key":"R16-3-20210226","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJM197712012972201","article-title":"Legionnaires' disease: description of an epidemic of pneumonia.","volume":"297","author":"Fraser","year":"1977","journal-title":"N Engl J Med"},{"key":"R17-3-20210226","first-page":"100","article-title":"Immunologic response and pathophysiology of Legionella infection.","volume":"13","author":"Friedman","year":"1998","journal-title":"Semin Respir Infect"},{"key":"R18-3-20210226","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/00365548609032343","article-title":"Prevalence of Legionnaires' disease in pneumonia patients admitted to a Danish department of infectious diseases.","volume":"18","author":"Friis-Moller","year":"1986","journal-title":"Scand J Infect Dis"},{"key":"R19-3-20210226","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijantimicag.2006.03.029","article-title":"Impact of rifampicin addition to clarithromycin in Legionella pneumophila pneumonia.","volume":"28","author":"Grau","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"R20-3-20210226","first-page":"361","article-title":"Legionellosis in a bone marrow transplant center.","volume":"18","author":"Harrington","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"R21-3-20210226","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1084\/jem.154.5.1618","article-title":"Activated human monocytes inhibit the intracellular multiplication of Legionnaires' disease bacteria.","volume":"154","author":"Horwitz","year":"1981","journal-title":"J Exp Med"},{"key":"R22-3-20210226","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1084\/jem.153.2.398","article-title":"Interaction of the legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. II. Antibody promotes binding of L. pneumophila to monocytes but does not inhibit intracellular multiplication.","volume":"153","author":"Horwitz","year":"1981","journal-title":"J Exp Med"},{"key":"R23-3-20210226","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0025-6196(12)62667-6","article-title":"Legionella bozemanii pneumonia in an immunocompromised patient.","volume":"63","author":"Jaeger","year":"1988","journal-title":"Mayo Clin Proc"},{"key":"R24-3-20210226","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/jac\/46.3.385","article-title":"The effect of azithromycin on intracellular Legionella pneumophila in the Mono Mac 6 cell line at serum concentrations attainable in vivo.","volume":"46","author":"Jonas","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"R25-3-20210226","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00005792-198005000-00002","article-title":"Legionnaires' disease: report of sixty-five nosocomially acquired cases and review of the literature.","volume":"59","author":"Kirby","year":"1980","journal-title":"Medicine (Baltimore)"},{"key":"R27-3-20210226","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2307\/30142014","article-title":"More than 10 years of unrecognized nosocomial transmission of legionnaires' disease among transplant patients.","volume":"19","author":"Kool","year":"1998","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R28-3-20210226","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jac\/22.3.389","article-title":"Failure of treatment of legionella pneumonia with ciprofloxacin.","volume":"22","author":"Kurz","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"R29-3-20210226","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1128\/JCM.31.10.2764-2768.1993","article-title":"Growth of 28 Legionella species on selective culture media: a comparative study.","volume":"31","author":"Lee","year":"1993","journal-title":"J Clin Microbiol"},{"key":"R30-3-20210226","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1378\/chest.109.5.1243","article-title":"Legionella species community-acquired pneumonia. A review of 56 hospitalized adult patients.","volume":"109","author":"Lieberman","year":"1996","journal-title":"Chest"},{"key":"R32-3-20210226","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/archinte.1994.00420210049006","article-title":"Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality.","volume":"154","author":"Marston","year":"1994","journal-title":"Arch Intern Med"},{"key":"R33-3-20210226","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1128\/AAC.40.6.1419","article-title":"In vitro synergy testing of macrolide-quinolone combinations against 41 clinical isolates of Legionella.","volume":"40","author":"Martin","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"R34-3-20210226","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/clinids\/5.2.258","article-title":"Legionella infections: a review of five years of research.","volume":"5","author":"Meyer","year":"1983","journal-title":"Rev Infect Dis"},{"key":"R35-3-20210226","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1432-2277.2005.00135.x","article-title":"Tacrolimus-azithromycin interaction in a recipient of allogeneic bone marrow transplantation.","volume":"18","author":"Mori","year":"2005","journal-title":"Transpl Int"},{"key":"R36-3-20210226","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1086\/342884","article-title":"Infection due to Legionella species other than L. pneumophila.","volume":"35","author":"Muder","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R37-3-20210226","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/428059","article-title":"Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy.","volume":"40","author":"Mykietiuk","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"Suppl C","key":"R38-3-20210226","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jac\/37.suppl_C.133","article-title":"Drug interactions with azithromycin and the macrolides: an overview.","volume":"37","author":"Nahata","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"R39-3-20210226","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1172\/JCI111493","article-title":"Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone.","volume":"74","author":"Nash","year":"1984","journal-title":"J Clin Invest"},{"key":"R40-3-20210226","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/mpo.2950140205","article-title":"Legionnaires' disease in patients with cancer.","volume":"14","author":"Nunnink","year":"1986","journal-title":"Med Pediatr Oncol"},{"key":"R41-3-20210226","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1592\/phco.21.17.1436.34434","article-title":"Possible interaction between intravenous azithromycin and oral cyclosporine.","volume":"21","author":"Page","year":"2001","journal-title":"Pharmacotherapy"},{"issue":"Suppl 3","key":"R42-3-20210226","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1469-0691.2006.01394.x","article-title":"Legionella: macrolides or quinolones?","volume":"12","author":"Pedro-Botet","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"R43-3-20210226","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1183\/09031936.95.08111929","article-title":"Nosocomial and community-acquired Legionella pneumonia: clinical comparative analysis.","volume":"8","author":"Pedro-Botet","year":"1995","journal-title":"Eur Respir J"},{"key":"R44-3-20210226","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/516258","article-title":"Role of immunosuppression in the evolution of Legionnaires' disease.","volume":"26","author":"Pedro-Botet","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"R45-3-20210226","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/S0924-8579(01)00397-1","article-title":"Comparative safety of the different macrolides.","volume":"18","author":"Rubinstein","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"R46-3-20210226","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF02714926","article-title":"The incidence of legionella pneumonia: a 1-year prospective study in a large community hospital.","volume":"167","author":"Ruf","year":"1989","journal-title":"Lung"},{"key":"R47-3-20210226","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1378\/chest.128.3.1401","article-title":"Fluoroquinolones vs macrolides in the treatment of Legionnaires disease.","volume":"128","author":"Sabria","year":"2005","journal-title":"Chest"},{"key":"R48-3-20210226","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/clinids\/17.3.518","article-title":"Unsuccessful treatment of Legionella pneumophila infection with a fluoroquinolone.","volume":"17","author":"Salord","year":"1993","journal-title":"Clin Infect Dis"},{"key":"R49-3-20210226","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00321056","article-title":"Fatal legionellosis in patients with malignant hematologic diseases.","volume":"56","author":"Schurmann","year":"1988","journal-title":"Blut"},{"key":"R50-3-20210226","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijantimicag.2004.08.019","article-title":"Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing.","volume":"25","author":"Stout","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"R51-3-20210226","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1378\/chest.117.2.398","article-title":"The radiologic manifestations of Legionnaire's disease. The Ohio Community-Based Pneumonia Incidence Study Group.","volume":"117","author":"Tan","year":"2000","journal-title":"Chest"},{"key":"R52-3-20210226","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jac\/dki159","article-title":"Pharmacodynamic studies of moxifloxacin and erythromycin against intracellular Legionella pneumophila in an in vitro kinetic model.","volume":"56","author":"Tano","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"R53-3-20210226","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/clinids\/20.2.329","article-title":"Legionella bozemanii cavitary pneumonia poorly responsive to erythromycin: case report and review.","volume":"20","author":"Taylor","year":"1995","journal-title":"Clin Infect Dis"},{"key":"R54-3-20210226","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1086\/515040","article-title":"Epidemiology of legionella pneumonia and factors associated with legionella-related mortality at a tertiary care center.","volume":"27","author":"Tkatch","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R55-3-20210226","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1378\/chest.125.6.2135","article-title":"Levofloxacin efficacy in the treatment of community-acquired legionellosis.","volume":"125","author":"Yu","year":"2004","journal-title":"Chest"},{"key":"R56-3-20210226","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0002-9343(82)90727-6","article-title":"Legionnaires' disease: new clinical perspective from a prospective pneumonia study.","volume":"73","author":"Yu","year":"1982","journal-title":"Am J Med"},{"key":"R57-3-20210226","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1086\/341087","article-title":"Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey.","volume":"186","author":"Yu","year":"2002","journal-title":"J Infect Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0b013e3181779b53","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:04:18Z","timestamp":1786035858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-200805000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e3181779b53","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}